VSee Health settles lender default with share issuances and promissory notes
Small emerging-growth healthcare technology companies have found equity-line financing a fraught lifeline in the current rate environment, where compliance timelines can tip into default faster than capital markets move. Against…
Key takeaways
- VSee Health, Inc. (Nasdaq: VSEE) disclosed on July 24, 2026 that it settled a debt dispute with creditors ADI Funding LLC and M2B Funding Corp. through cash, new promissory notes, and stock issuances.
- The dispute stemmed from an alleged event of default on a $271,739.13 secured promissory note held by ADI, triggered by VSee Health's failure to meet SEC filing and registration obligations due by June 11, 2026.
- The settlement requires VSee Health to pay ADI $50,000 in cash within three business days, issue a $50,000 note to ADI and a $125,000 note to M2B, and issue 500,000 restricted shares each to ADI and M2B.
- The original $271,739.13 note must be repaid within 90 days starting July 21, 2026, or immediately upon receiving financing proceeds, with 50% of most financing proceeds flowing to ADI until repaid.
- The two settlement notes carry no interest before maturity but reset retroactively to 18% per annum if unpaid, and are convertible into common stock at 75% of the lowest 20-day VWAP preceding conversion.
Small emerging-growth healthcare technology companies have found equity-line financing a fraught lifeline in the current rate environment, where compliance timelines can tip into default faster than capital markets move. Against that backdrop, VSee Health, Inc. (Nasdaq: VSEE) disclosed on July 24, 2026 that it had settled a debt dispute with two creditors through a package of cash payments, new promissory notes, and stock issuances. The settlement, executed July 21, 2026, resolves claims tied to a $271,739.13 secured promissory note and an equity line of credit the company failed to register on schedule.
The dispute that triggered the agreement
ADI Funding LLC held the $271,739.13 secured note, originally issued June 8, 2026. On June 12, 2026, ADI notified VSee Health of an alleged event of default, citing the company's failure to file a Form S-1 resale registration statement for shares connected to an equity line of credit with M2B Funding Corp., failure to file a Form 8-K disclosing that arrangement, and failure to deliver transfer agent instructions for M2B commitment shares. All three obligations were due no later than June 11, 2026.
What VSee Health agreed to pay
The settlement requires VSee Health to repay the existing note within 90 days or immediately upon receiving proceeds from any financing transaction. Until the note is cleared, 50% of gross proceeds from most financing transactions flow to ADI. Proceeds from the equity line itself go 100% to ADI until repaid in full.
Cash and notes make up the near-term burden. VSee Health must pay ADI $50,000 in cash within three business days of signing, with a $500-per-day late charge if the deadline is missed. The company will also issue ADI a separate $50,000 promissory note maturing in six months. M2B receives a $125,000 promissory note on the same timeline. Both notes carry no interest before maturity but reset at 18% per annum, retroactively, if unpaid at the due date. Each holder may convert the outstanding balance into common stock at 75% of the lowest volume-weighted average price over the 20 trading days preceding conversion.
Beyond the notes, VSee Health will issue 500,000 shares of restricted common stock to ADI and a further 500,000 shares to M2B, each carrying piggyback registration rights.
Default risk and the macro read-through
The settlement carries its own default triggers. Failure to pay, failure to issue shares or notes, failure to file the required Form 8-K, or breach of any material covenant accelerates all obligations immediately, imposes 18% interest, makes conversion rights exercisable at once, and reinstates ADI's full rights under the original transaction documents.
The read-through for the broader cycle is pointed. Small healthcare technology companies relying on equity lines to fund operations face a compliance burden that is tightly interwoven with their financing access. A missed SEC filing deadline on June 11 produced a default notice by June 12. On balance, the cost of resolution here spans cash, two settlement notes totaling $175,000 in principal, and one million new restricted shares. The 90-day repayment clock on the original $271,739.13 note began July 21.
Related reading
Source · 來源